PTC Therapeutics Inc (PTCT) — Cash Flow Quality Index
PTC Therapeutics Inc (PTCT) has a Cash Flow Quality Index of -4.17x as of September 2025. Operating cash flow of $-66.30 Million is below net income of $15.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PTCT cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PTC Therapeutics Inc Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for PTC Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of PTC Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PTC Therapeutics Inc (2011–2025)
Year-by-year earnings quality comparison for PTC Therapeutics Inc. For live market cap and the full company financial profile, see PTCT stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | $711.20 Million | $682.64 Million | ▲ +255.0% |
| 2011 | -0.67x | $-20.77 Million | $30.90 Million | — |